Top Markets
Coin of the day
Cyteir Therapeutics, Inc. Cyteir Therapeutics, Inc.

Cyteir Therapeutics, Inc.

CYT
Classifica tra le azioni #21570
Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated... Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to innovating and bringing to market cutting-edge precision oncology medicines. Its flagship compound, CYT-0851, is an novel, orally administered small molecule drug candidate, designed for once-daily dosing. This therapy is currently undergoing Phase I/II clinical evaluations, both as a standalone treatment and in combination with other drugs, targeting a broad range of solid tumors and hematologic malignancies. Furthermore, the company is advancing CYT-1853, another promising candidate in preclinical development for similar oncological indications. Cyteir Therapeutics was established in 2012 and is headquartered in Lexington, Massachusetts.
Prezzo delle azioni
$3.01
Ultima sincronizzazione: 2024-04-12
Capitalizzazione di mercato
$104.64M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Cyteir Therapeutics, Inc. (CYT)

Categoria

Storico del prezzo dell'azione per Cyteir Therapeutics, Inc. (CYT)
Prezzo di chiusura più alto: $3.01 il 2024-04-01

Prezzo di chiusura più basso: $18.73 il 2021-06-01
Storico del prezzo dell'azione di Cyteir Therapeutics, Inc. dal 2021 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2024 -2.00%
2023 125.69%
2022 -88.47%
2021 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH